Document Details
Form
Filing Date
Jul 25, 2019
Document Date
Jul 24, 2019
Form Description
Initial filing by director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
Turning Point Therapeutics, Inc.
Issuer
Turning Point Therapeutics, Inc.
Filer
Gallagher Carol Giltner
Turning Point Therapeutics is now a
Bristol Myers Squibb company
Select OK for information about Turning Point Therapeutics.
Select BMS to learn more about Bristol Myers Squibb